Bacterial vaginosis can have significant implications for women's reproductive and gynecological health. Untreated or recurrent BV may increase the risk of complications, including preterm birth, low birth weight, and an increased susceptibility to sexually transmitted infections (STIs). Additionally, BV has been associated with an elevated risk of pelvic inflammatory disease (PID), which can lead to long-term reproductive health issues. Therefore, prompt diagnosis and treatment are essential to mitigate these potential complications. Preventing bacterial vaginosis involves adopting practices that maintain a healthy vaginal environment. This includes avoiding douching, using mild soap for external cleansing, and wearing breathable cotton underwear. Regular gynecological check-ups and screenings can aid in early detection and management of BV. Health education initiatives are also crucial in raising awareness about risk factors, symptoms, and preventive measures related to bacterial vaginosis. By promoting a comprehensive understanding of BV, healthcare professionals and communities can work together to reduce its prevalence and impact on women's reproductive health.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain